Stock Market logoStock Market Station

All the stock market news, every minute updated!

06 August 2021
04:33 hour

Ovid Therapeutics appoints Jeff Rona as CFO

Seeking Alpha

04/06/2021 - 14:11


READ THE FULL ARTICLE ON SEEKING ALPHA

Related headlines:

  1. Ovid Therapeutics EPS misses by $0.04, beats on revenue (15/03/2021 - Seeking Alpha)

    [visit article]
  2. Ovid Therapeutics dips 3% as Cantor downgrades on pipeline setbacks (20/04/2021 - Seeking Alpha)

    [visit article]
  3. Ovid Therapeutics names Jason Tardio Chief Operating Officer (08/07/2021 - Seeking Alpha)

    [visit article]
  4. Ovid Therapeutics, KemPharm leads healthcare gainers; Vir Biotechnology, NanoViricides among major losers (03/03/2021 - Seeking Alpha)

    [visit article]
  5. Angi appoints Jeff Pedersen as CFO (24/06/2021 - Seeking Alpha)

    [visit article]
  6. Ovid Therapeutics EPS beats by $1.80, beats on revenue (13/05/2021 - Seeking Alpha)

    [visit article]
  7. C4 Therapeutics appoints new CFO (20/05/2021 - Seeking Alpha)

    [visit article]
  8. Stocks to Watch 03/03/2021 (03/03/2021 - Reddit Stock Market)
    Good morning, Apologies for my absence over the last two days; it's been a busy week so far for me and I haven't been able to trade until today. Here is my gap watchlist today. $KMPH (KemPharm) - Essentially the joint leading gapper today, and on short sale restriction. Up 71% with 9M volume and tight spreads (4 cents) so definitely one to watch today. Strong catalyst here as well as it's moving on news of FDA approving their ADHD drug. This will be interesting if it gets over the VWAP ($16.60 currently). $OVID (Ovid Therapeutics) - We saw this rip a little earlier and it is currently at the top of my gap scanners. There is a bit of a flat-top occurring at around the 60 cents level, but a break above the premarket high of $6.11 could see some bullish action. Volume is still very high here so there is potential, but there is similarly a high float (53.1M). I don't think this is as interesting as KMPH just yet. $OCGN (Ocugen) - This stock is gapping up again following more COVID-related news. This has been a hot stock for most of Feb and it has made some huge moves recently. As always, I will be looking for a break of VWAP with a shape like this. Both KMPH and OVID, whilst certainly 'leading' this morning aren't exciting me yet. They are both choppy and seem indecisive. In conditions like these, I like to look for promising dip trades, especially those which occur around key levels with as the half-dollar and dollar levels. As a reminder, trading is risky, make sure you put stops in place and follow your initial plan regardless. Have a good week. -Rep   submitted by   /u/RepinskiUK [link]   [comments]
    [visit article]
  9. Qualigen Therapeutics appoints Tariq Arshad as CMO (19/05/2021 - Seeking Alpha)

    [visit article]
  10. Rubius Therapeutics appoints new operations chief (29/07/2021 - Seeking Alpha)

    [visit article]
  11. Keros Therapeutics appoints Simon Cooper as CMO (02/08/2021 - Seeking Alpha)

    [visit article]
  12. Abeona Therapeutics appoints Michael Amoroso as CEO (22/03/2021 - Seeking Alpha)

    [visit article]
  13. Nurix Therapeutics appoints new operations chief (21/06/2021 - Seeking Alpha)

    [visit article]
  14. TCR2 Therapeutics appoints Peter Olagunju as CTO (20/07/2021 - Seeking Alpha)

    [visit article]
  15. Cyclo Therapeutics scales high, appoints chief commercial officer (10/03/2021 - Seeking Alpha)

    [visit article]
  16. Cerevel Therapeutics creates a new president role, appoints industry veteran (21/04/2021 - Seeking Alpha)

    [visit article]
  17. Cerevel Therapeutics creates a new president role, appoints industry veteran (21/04/2021 - Seeking Alpha)

    [visit article]
  18. StckLife after the 'rona (10/06/2021 - Reddit Stock Market)
    Its no secret, the whole 'rona situation messed up the stock market completely. Stocks that should have exponential growth lost money. Stocks that should perish got mooned. Some examples are the bio comp. MRNA got x9 value since the whole outbreak started. Meanwhile, WMT (possibly the most well-known retail company in the US) barely made +15% on the same timespan. How do you think the "end" of the pandemic (possibly this fall) is gonna affect our stocks? Do you expect sudden plummet of some of those companies that mooned during these tough years? Do you think companies that got staled will jumpstart again? Im asking as a newb, I want to pick your brains to see what a pro investor thinks.   submitted by   /u/pinelakias [link]   [comments]
    [visit article]
  19. QTRX, QK, PFIN and OVID among after-hours movers (01/04/2021 - Seeking Alpha)

    [visit article]
  20. Ovid shares surge 92% after soticlestat deal with Takeda (03/03/2021 - Seeking Alpha)

    [visit article]
  21. Ovid downgraded to sector perform at RBC as shares surge 34% on Takeda deal (03/03/2021 - Seeking Alpha)

    [visit article]
  22. Benitec Biopharma, Hoth Therapeutics leads healthcare gainers; Frequency Therapeutics, Windtree Therapeutics among major losers (23/03/2021 - Seeking Alpha)

    [visit article]
  23. Enochian Biosciences, RAPT Therapeutics leads healthcare gainers; Avenue Therapeutics, Inhibikase Therapeutics among major losers (14/06/2021 - Seeking Alpha)

    [visit article]
  24. Asensus Surgical, Nabriva Therapeutics leads healthcare gainers; Larimar Therapeutics, Travere Therapeutics among major losers (26/05/2021 - Seeking Alpha)

    [visit article]
  25. The Margin: Why over 66,000 people want Jeff Bezos to stay in space (21/06/2021 - Market Watch)
    ‘Do not allow Jeff Bezos to return to Earth’ reads one petition against the Amazon founder’s re-entry during his Blue Origin flight
    [visit article]
  26. Push for Merck to work with GSK on vaccine, Ovid price target halved, and more in today's analyst action action (20/04/2021 - Seeking Alpha)

    [visit article]
  27. Key Words: Elizabeth Warren suggests Jeff Bezos is going to space at taxpayers’ expense: ‘He’s laughing at every person in America who actually paid taxes’ (11/06/2021 - Market Watch)
    "Jeff Bezos’s trip to outer space is being financed by all the rest of the U.S. taxpayers who paid their taxes so that Jeff Bezos didn’t have to," Warren says.
    [visit article]
  28. Key Words: Elizabeth Warren suggests Jeff Bezos is going to space at taxpayers’ expense: ‘He’s laughing at every person in America who actually paid taxes’ (11/06/2021 - Market Watch)
    "Jeff Bezos’s trip to outer space is being financed by all the rest of the U.S. taxpayers who paid their taxes so that Jeff Bezos didn’t have to," Warren says.
    [visit article]
  29. The Wall Street Journal: Jeff Bezos — and other space tourists — fly at their own risk (11/06/2021 - Market Watch)
    When Jeff Bezos climbs into the New Shepard capsule for its first passenger trip to space next month, his safety will be almost entirely in the hands of the spaceflight company he founded two decades ago.
    [visit article]
  30. Jeff Bezos will fly on the first passenger spaceflight of Blue Origin in July (07/06/2021 - Reddit Stocks)
    Jeff Bezos will fly on the first passenger flight of his space company Blue Origin The company plans to launch the mission on July 20, the billionaire announced on Monday. Bezos’ brother will join him, as well as the winner of a public auction being held for one of the seats. https://www.cnbc.com/2021/06/07/jeff-bezos-to-fly-on-blue-origin-first-passenger-flight-in-july.html   submitted by   /u/i_like_dolphins_ [link]   [comments]
    [visit article]
  31. Aragen partners with Skyhawk Therapeutics to develop novel small molecule therapeutics (16/07/2021 - Financial Express)
    Hyderabad based Contract Research and Development Organization (CRDO) Aragen Life Sciences (formerly, GVK BIO) has announced that it has been selected by Skyhawk Therapeutics, a leader in the development of small molecule therapeutics that correct RNA expression, as its partner in India.
    [visit article]
  32. : For a day, Jeff Bezos wasn’t the world’s richest. Here’s who was. (25/05/2021 - Market Watch)
    LVMH CEO Bernard Arnault is battling Amazon CEO Jeff Bezos for the title of world's richest.
    [visit article]
  33. Its the perfect time to buy into Qualigen Therapeutics (22/03/2021 - Reddit Stocks)
    Qualigen Therapeutics is at one of its all time lows. Right now is a great time to buy in. I just dropped all of my money into it, and Limelight Networks. What do you all think about Qualigen Therapeutics?   submitted by   /u/420nion [link]   [comments]
    [visit article]
  34. The Margin: Jeff Bezos is no longer the richest person on the planet after he loses $13.9 billion in one day (02/08/2021 - Market Watch)
    Jeff Bezos momentarily forfeited his title of “richest person on the planet” on July 20 when his Blue Origin spacecraft reached suborbital flight for a few minutes. Now, the multibillionaire is once again without the title.
    [visit article]
  35. Jeff Bezos becomes world’s richest person again as Elon Musk fortune falls with Tesla share price (17/02/2021 - Financial Express)
    Tesla chief Elon Musk’s net worth now stands at $190 billion while that of Jeff Bezos is at $191 billion.
    [visit article]
  36. OPKO Health licenses oligonucleotide therapeutics platform to CAMP4 Therapeutics (12/07/2021 - Seeking Alpha)

    [visit article]
  37. NovoCure, vTv Therapeutics leads healthcare gainers; Avenue Therapeutics, AdaptHealth among major losers (13/04/2021 - Seeking Alpha)

    [visit article]
  38. Clene, Inhibikase Therapeutics leads healthcare gainers; IMV, Tempest Therapeutics among major losers (15/07/2021 - Seeking Alpha)

    [visit article]
  39. Cerevel Therapeutics, Avinger leads healthcare gainers; DiaMedica Therapeutics, MediWound among major losers (29/06/2021 - Seeking Alpha)

    [visit article]
  40. Intellia Therapeutics, Verve Therapeutics leads healthcare gainers; CEL-SCI, Acurx Pharmaceuticals among major losers (28/06/2021 - Seeking Alpha)

    [visit article]
  41. Aethlon Medical, Checkpoint Therapeutics leads healthcare gainers; Atossa Therapeutics, CEL-SCI among major losers (09/06/2021 - Seeking Alpha)

    [visit article]
  42. Millendo Therapeutics shareholders approve merger with Tempest Therapeutics (22/06/2021 - Seeking Alpha)

    [visit article]
  43. Windtree Therapeutics, Senseonics leads healthcare gainers; Harpoon Therapeutics, Purple Biotech among major losers (04/06/2021 - Seeking Alpha)

    [visit article]
  44. Tempest Therapeutics, Xtant Medical leads healthcare gainers; Sigilon Therapeutics, TransMedics among major losers (12/07/2021 - Seeking Alpha)

    [visit article]
  45. Chemomab Therapeutics, Obalon Therapeutics leads healthcare gainers; Haemonetics, 180 Life Sciences among major losers (19/04/2021 - Seeking Alpha)

    [visit article]
  46. Freeline Therapeutics, Cytokinetics leads healthcare gainers; China SXT Pharmaceuticals, Atossa Therapeutics among major losers (19/07/2021 - Seeking Alpha)

    [visit article]
  47. Amazon India looking to buy stake in Inox Leisure, others; Jeff Bezos hunting for media bargain buys (27/07/2021 - Financial Express)
    Jeff Bezos is looking to diversify Amazon India’s entertainment business with eyes on acquiring multiple film and media distribution players, including Mumbai-based movie theatre chain Inox Leisure.
    [visit article]
  48. Galera Therapeutics, Ocular Therapeutix leads healthcare gainers; Adverum Biotechnologies, Cara Therapeutics among major losers (29/04/2021 - Seeking Alpha)

    [visit article]
  49. Galectin Therapeutics, ReShape Lifesciences leads healthcare gainers; Sigilon Therapeutics, Aerpio Pharmaceuticals among major losers (09/07/2021 - Seeking Alpha)

    [visit article]

For more information mailto [email protected]. Disclaimer.